Resmed (RMD) Cash from Operations (2009 - 2026)

Resmed's Cash from Operations history runs 18 years deep, the most recent figure standing at 554132000.0 for Q1 2026.

• Quarterly Cash from Operations fell 4.24% year-over-year to 554132000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1889964000.0 (up 14.34% YoY) and the FY2025 annual result came in at 1751588000.0, up 25.0% from the prior year.
• Cash from Operations was 554132000.0 for Q1 2026 at Resmed, up from 339745000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 578661000.0 in Q1 2025 and bottomed at 44662000.0 in Q3 2022.
• A 5-year average of 317310000.0 and a median of 308623000.0 in 2024 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations plunged 64.91% — and 2023, when it surged 541.0%.
• Resmed's Cash from Operations stood at 128636000.0 in 2022, then jumped by 112.1% to 272832000.0 in 2023, then grew by 13.12% to 308623000.0 in 2024, then advanced by 10.08% to 339745000.0 in 2025, then surged by 63.1% to 554132000.0 in 2026.
• Business Quant data shows RMD's Cash from Operations at 554132000.0 in Q1 2026, 339745000.0 in Q4 2025, and 457321000.0 in Q3 2025.